Healthcare
Live Price
Offline$127.06
+2.20% today
1Y Change
+13.01%
Window
Jun 20, 2025 → Jun 15, 2026
Coverage: 247 bars · Jun 20, 2025 → Jun 15, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Agilent Technologies, Inc. (A) is a Healthcare stock with a market cap of $31.70B and listed on NYSE. The stock last traded around $127.06 and up 13.0% across the available one-year price window (Jun 20, 2025 → Jun 15, 2026). Baseline metrics include revenue growth of +6.7%, EPS growth of +3.4%, a dividend yield of 0.7%. What stands out right now is revenue +6.7%, EPS +3.4%, free cash flow -16.1% with operating margin 20.6% and ROIC 12.1%. The dividend is present but secondary, with a yield around 0.7%. Valuation sits in the middle of the pack at P/E 24.6 and price/sales 4.5. Stock Foundry combines A price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
A
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
A Max Drawdown
-29.87%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for A and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$6.3B
-7.7% YoY
FY Net Income
$1.2B
-3.5% YoY
Free Cash Flow
$1.3B
+26.9% YoY
Revenue Growth
+6.7%
EPS Growth
+3.4%
Gross Margin
52.2%
Net Margin
18.3%
Income statement
USD
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 6.9B | 6.5B | 6.8B | 6.8B | 6.3B |
| Gross Profit | 3.6B | 3.5B | 3.5B | 3.7B | 3.4B |
| Operating Income | 1.5B | 1.5B | 1.4B | 1.6B | 1.3B |
| EBITDA | 1.8B | 1.9B | 1.7B | 1.9B | 1.8B |
| Net Income | 1.3B | 1.3B | 1.2B | 1.3B | 1.2B |
| EPS (Diluted) | — | — | — | — | — |
Balance sheet
USD
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Cash & Equivalents | 1.8B | 1.3B | 1.6B | 1.1B | 1.5B |
| Total Assets | 12.7B | 11.8B | 10.8B | 10.5B | 10.7B |
| Total Liabilities | 6.0B | 5.9B | 4.9B | 5.2B | 5.3B |
| Shareholder Equity | 6.7B | 5.9B | 5.8B | 5.3B | 5.4B |
| Total Debt | 3.4B | 3.6B | 2.7B | 2.8B | 2.7B |
| Net Debt | 1.6B | 2.2B | 1.1B | 1.7B | 1.2B |
Cash flow positioning
Latest Full Year
Operating Cash Flow
1.5B
+13.2% YoY
Capital Expenditures
189M
+35.1% YoY
Free Cash Flow
1.3B
+26.9% YoY
Key ratios
Gross Margin
52.2%
Operating Margin
20.6%
Net Margin
18.3%
ROE
19.7%
Debt / Equity
0.49x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.